Talk:EUROMIT2023 Bologna IT: Difference between revisions
From Bioblast
Beno Marija (talk | contribs) m (Beno Marija moved page Talk:EUROMIT2023 Newcastle upon Tyne UK to Talk:EUROMIT2023 Bologna IT) |
No edit summary |
||
| Line 1: | Line 1: | ||
== Submitted abstracts == | |||
::::* Komlódi T, Silva FSG, Duarte AI, Mena D, Garcia-Souza LF, Makrecka-Kuka M, Bento G, Grilo LF, Oliveira PJ, Gnaiger E (2023) Off-target effects of etomoxir: inhibition of mitochondrial Complex I and fatty acid oxidation. | |||
::::* Timón-Gómez A, Cardoso L, Doerrier C, Garcia-Souza LF, Gnaiger E (2023) A reference substrate-uncoupler-inhibitor titration reference protocol for diagnostic OXPHOS analysis to create a mitochondrial coupling and pathway control database. | |||
::::* Balmaceda V, Komlodi T, Zeviani M, Gnaiger E, Moore AL, Fernandez-Vizarra E, Viscomi C (2023) Tissue-specific bioenergetics in mouse models of mitochondrial disease. | |||
::::* Torres-Quesada O, Strich S, Feichtner A, Schwaighofer S, Doerrier C, Schmitt S, Gnaiger E, Stefan E (2023) Mitochondrial profiling of kinase inhibitors in cancer cell models reveals drug off-target drug effects. | |||
::::* Munich | |||
::::* Jena | |||
Latest revision as of 11:39, 8 March 2023
Submitted abstracts
- Komlódi T, Silva FSG, Duarte AI, Mena D, Garcia-Souza LF, Makrecka-Kuka M, Bento G, Grilo LF, Oliveira PJ, Gnaiger E (2023) Off-target effects of etomoxir: inhibition of mitochondrial Complex I and fatty acid oxidation.
- Timón-Gómez A, Cardoso L, Doerrier C, Garcia-Souza LF, Gnaiger E (2023) A reference substrate-uncoupler-inhibitor titration reference protocol for diagnostic OXPHOS analysis to create a mitochondrial coupling and pathway control database.
- Balmaceda V, Komlodi T, Zeviani M, Gnaiger E, Moore AL, Fernandez-Vizarra E, Viscomi C (2023) Tissue-specific bioenergetics in mouse models of mitochondrial disease.
- Torres-Quesada O, Strich S, Feichtner A, Schwaighofer S, Doerrier C, Schmitt S, Gnaiger E, Stefan E (2023) Mitochondrial profiling of kinase inhibitors in cancer cell models reveals drug off-target drug effects.
- Munich
- Jena
